Carisma Therapeutics
CARM · NASDAQ
$0.0005+$0.0003 (+150.00%)TodayMarket closed ·
Prev close $0.0002
Who owns CARM
Largest institutional holders, from their latest 13F filings
The 9 largest institutions hold 33.8% of CARM’s shares.
- Modernatx Inc12.1%
- Longview Innovation Corp6.5%
- Wellington Partners Venture Capital GmbH5.5%
- SymBiosis Capital Management, LLC5.3%
- Next 5 largest institutions4.5%
- All other shareholders66.2%
| Holder | Shares | % of shares |
|---|---|---|
| Modernatx Inc | 5.06M | 12.09% |
| Longview Innovation Corp | 2.71M | 6.48% |
| Wellington Partners Venture Capital GmbH | 2.30M | 5.49% |
| SymBiosis Capital Management, LLC | 2.22M | 5.29% |
| Abbvie Biotechnology Ltd | 1.86M | 4.43% |
| Morrison (Briggs W. M.D.) | 12.18K | 0.03% |
| Union Bancaire Privée, UBP SA | 785 | 0.00% |
| Zweifach (Sanford S) | 413 | 0.00% |
| ORG Partners LLC | 200 | 0.00% |
Short interest
Settled Sep 30, 2026
- Shares short
- 6.46K
- Days to cover
- 1.26
- % of shares outstanding
- 0.02%
- Average daily volume
- 5.15K
- Change since last report
- +0.0%
Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.